FDA Drug Shortage Database
Clindamycin (Cleocin) shortage
The FDA Drug Shortage Database lists 6 of 28 clindamycin presentations as limited or unavailable (updated October 2, 2026); the first entry was posted on March 21, 2023. 11 more presentations are on the list as available.
- Generic listed
- In shortage
- Boxed warning
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 5% injection | 0 | 5 | 0 |
| 75mg capsule | 0 | 0 | 1 |
| 75mg/5ml injection | 0 | 0 | 1 |
| 150mg capsule | 0 | 0 | 1 |
| 150mg/1ml injection | 3 | 0 | 0 |
| 300mg capsule | 0 | 0 | 1 |
| 300mg/2ml injection | 1 | 0 | 2 |
| 300mg/50ml injection | 0 | 3 | 0 |
| 600mg/4ml injection | 0 | 1 | 2 |
| 600mg/50ml injection | 1 | 0 | 0 |
| 900mg/50ml injection | 1 | 1 | 0 |
| 900mg/6ml injection | 0 | 1 | 2 |
Which presentations are listed?
Limited or unavailable now (6)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26) | Pfizer Inc. | Current posted March 21, 2023, updated September 21, 2026 | Unavailable; Demand increase for the drug |
| Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-02) | Sagent Pharmaceuticals | Current posted March 21, 2023, updated September 18, 2026 | Limited Availability; Discontinuation of the manufacture of the drug |
| Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-04) | Sagent Pharmaceuticals | Current posted March 21, 2023, updated September 18, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06) | Sagent Pharmaceuticals | Current posted March 21, 2023, updated September 18, 2026 | Limited Availability; Discontinuation of the manufacture of the drug |
| Clindamycin Phosphate, Injection, 600 mg/50 mL (NDC 0338-3612-50) | Baxter Healthcare | Current posted March 21, 2023, updated October 2, 2026 | Unavailable; Demand increase for the drug |
| Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50) | Baxter Healthcare | Current posted March 21, 2023, updated October 2, 2026 | Unavailable; Demand increase for the drug |
Listed now, available (11)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26) | Pfizer Inc. | Current posted March 21, 2023, updated September 21, 2026 | Available |
| Cleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18) | Pfizer Inc. | Current posted March 21, 2023, updated September 21, 2026 | Available |
| Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09) | Sandoz Inc. | Current posted March 21, 2023, updated September 18, 2026 | Available |
| Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24) | Sandoz Inc. | Current posted March 21, 2023, updated September 18, 2026 | Available |
| Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09) | Sandoz Inc. | Current posted March 21, 2023, updated September 18, 2026 | Available |
| Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24) | Sandoz Inc. | Current posted March 21, 2023, updated September 18, 2026 | Available |
| Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09) | Sandoz Inc. | Current posted March 21, 2023, updated September 18, 2026 | Available |
| Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-3410-50) | Baxter Healthcare | Current posted March 21, 2023, updated October 2, 2026 | Available |
| Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9545-50) | Baxter Healthcare | Current posted March 21, 2023, updated October 2, 2026 | Available |
| Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9549-50) | Baxter Healthcare | Current posted March 21, 2023, updated October 2, 2026 | Available |
| Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-9553-50) | Baxter Healthcare | Current posted March 21, 2023, updated October 2, 2026 | Available |
Resolved or discontinued (10)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Cleocin Hydrochloride, Capsule, 150 mg (NDC 0009-0225-02) | Pfizer Inc. | To Be Discontinued posted February 25, 2026, updated February 25, 2026 | not given |
| Cleocin Hydrochloride, Capsule, 300 mg (NDC 0009-0395-14) | Pfizer Inc. | To Be Discontinued posted February 25, 2026, updated February 25, 2026 | not given |
| Cleocin Hydrochloride, Capsule, 75 mg (NDC 0009-0331-02) | Pfizer Inc. | To Be Discontinued posted February 25, 2026, updated February 25, 2026 | not given |
| Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial (NDC 0009-0870-26) | Pfizer Inc. | To Be Discontinued posted June 1, 2026, updated June 1, 2026 | not given |
| Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial NovaPlus (NDC 0009-3051-02) | Pfizer Inc. | To Be Discontinued posted June 1, 2026, updated June 1, 2026 | not given |
| Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial (NDC 0009-0775-26) | Pfizer Inc. | To Be Discontinued posted June 1, 2026, updated June 1, 2026 | not given |
| Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial NovaPlus (NDC 0009-4073-04) | Pfizer Inc. | To Be Discontinued posted June 1, 2026, updated June 1, 2026 | not given |
| Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial (NDC 0009-0902-18) | Pfizer Inc. | To Be Discontinued posted June 1, 2026, updated June 1, 2026 | not given |
| Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial NovaPlus (NDC 0009-5095-06) | Pfizer Inc. | To Be Discontinued posted June 1, 2026, updated June 1, 2026 | not given |
| Clindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19) | Amneal Pharmaceuticals | To Be Discontinued posted February 27, 2026, updated February 27, 2026 | not given |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
Are medicines for the same conditions short too?
Medicines whose labels share an indication with this one, and their own shortage status; listed as records, not substitutes.
| Medicine | Shared indication | Shortage | Generic labelers | Pharmacy cost |
|---|---|---|---|---|
| Amoxicillin | Bacterial infections | No current entry | 38 labelers | $0.0788 per capsule 500 mg capsule |
| Azithromycin | Bacterial infections | A presentation being discontinued | 55 labelers | $0.266 per tablet 250 mg tablet |
| Cephalexin | Bacterial infections | No current entry | 35 labelers | $0.120 per capsule 500 mg capsule |
| Metronidazole | Bacterial infections | In shortage | 55 labelers | $0.102 per tablet 250 mg tablet |
| Sulfamethoxazole and trimethoprim | Bacterial infections | No current entry | 44 labelers | $0.0448 per tablet Sulfamethoxazole-tmp ds tablet |
| Levofloxacin | Bacterial infections | No current entry | 44 labelers | $0.259 per tablet 750 mg tablet |
| Cefdinir | Bacterial infections | No current entry | 26 labelers | $0.458 per capsule 300 mg capsule |
| Erythromycin | Bacterial infections | No current entry | 38 labelers | $1.96 per tablet 250 mg tablet |
| Clarithromycin | Bacterial infections | No current entry | 26 labelers | $0.466 per tablet 500 mg tablet |
| Cefuroxime | Bacterial infections | No current entry | 19 labelers | $0.280 per tablet 250 mg tablet |
| Cefadroxil | Bacterial infections | No current entry | 19 labelers | $0.269 per capsule 500 mg capsule |
| Cefpodoxime | Bacterial infections | No current entry | 11 labelers | $1.04 per tablet 100 mg tablet |
Source: FDA drug labels, FDA Drug Shortage Database, NDC Directory, CMS NADAC of October 7, 2026 (FDA files October 8, 2026)
What next?
- Every shortage now
- medicines by presentations in shortage